Efficacy of first-line tocilizumab therapy in early polymyalgia rheumatica: a prospective longitudinal study
Open accessAbstract
BACKGROUND: Glucocorticoids are the cornerstone treatment of polymyalgia rheumatica (PMR) but induce adverse events. OBJECTIVES: To evaluate the efficacy and safety of first-line tocilizumab in PMR. METHODS: In a prospective open-label study (ClinicalTrials.gov: NCT01713842), 20 glucocorticoid-free patients fulfilling Chuang's PMR criteria, with symptom onset within the last 12 months and a PMR activity score (PMR-AS) >10, each received three tocilizumab infusions at 4-week intervals, without glucocorticoids, followed by oral prednisone from weeks 12 to 24 (0.15 mg/kg if PMR-AS ≤10 and 0.30 mg/kg otherwise). The primary end point was the proportion of patients with PMR-AS≤10 at week 12. RESULTS: Baseline median PMR-AS was 36.6 (IQR 30.4-43.8). At week 12, all patients had PMR-AS≤10 and received the low prednisone dosage. Median PMR-AS at weeks 12 and 24 was 4.5 (3.2-6.8) and 0.95 (IQR 0.4-2), respectively (p<0.001 vs baseline for both time points). No patient required rescue treatment. Positron emission tomography-CT showed significant improvements. The most common adverse events were transient neutropenia (n=3) and leucopenia (n=5); in one patient, the second tocilizumab infusion was omitted due to leucopenia. CONCLUSIONS: Tocilizumab monotherapy is effective in recent-onset PMR. Randomised controlled trials are warranted. TRIAL REGISTRATION NUMBER: NCT01713842.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Tocilizumab is also effective and safe for polymyalgia rheumatica treatment.
“TCZ is also effective and safe for PMR treatment.114,115”
From Autoimmune diseases and immune-checkpoint inhibitors for cancer therapy: Review of the literature and personalized risk-based prevention strategy (2020) · cites this paper as [115]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Dasgupta, B., Cimmino, M. A., Kremers, H. M., Schmidt, W., Schirmer, M., Salvarani, C., Bachta, A., Dejaco, C., Duftner, C., Jensen, H. S., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200329 · Cited by 676 · see citing works
Chuang, T., HUNDER, G. G., ILSTRUP, D. M., & KURLAND, L. T. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-5-672 · Cited by 527 · see citing works
HUSKISSON, E. C., & HART, F. D. (1987) · Elsevier eBooks · doi:10.1016/b978-0-7236-0571-3.50187-7 · Cited by 436 · see citing works
Dejaco, C., Singh, Y. P., Perel, P., Hutchings, A., Camellino, D., Mackie, S. L., Abril, A., Bachta, A., Balint, P. V., Barraclough, K., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-207492 · Cited by 334 · see citing works
Dejaco, C., Singh, Y. P., Perel, P., Hutchings, A., Camellino, D., Mackie, S. L., Abril, A., Bachta, A., Balint, P. V., Barraclough, K., et al. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39333 · Cited by 312 · see citing works
Prednisone plus Methotrexate for Polymyalgia Rheumatica
Caporali, R. F., Cimmino, M. A., Ferraccioli, G., Gerli, R., Klersy, C., Salvarani, C., Montecucco, C., & for the Systemic Vasculitis Study Group of the Italian Society for Rheumatology (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-7-200410050-00005 · Cited by 260 · see citing works
BSR and BHPR guidelines for the management of polymyalgia rheumatica
Dasgupta, B., Borg, F., Hassan, N., Barraclough, K., Bourke, B., Fulcher, J., Hollywood, J., Hutchings, A., Kyle, V., Nott, J., et al. (2009) · Rheumatology · doi:10.1093/rheumatology/kep303a · Cited by 249 · see citing works
A disease activity score for polymyalgia rheumatica
Leeb, B. F., & Bird, H. A. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.011379 · Cited by 193 · see citing works
Carmona, F. D., Mackie, S. L., Martín, J., Taylor, J., Vaglio, A., Eyre, S., Bossini‐Castillo, L., Castañeda, S., Cid, M. C., Hernández‐Rodríguez, J., et al. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.02.009 · Cited by 177 · see citing works
Dejaco, C., Singh, Y. P., Perel, P., Hutchings, A., Camellino, D., Mackie, S. L., Matteson, E. L., & Dasgupta, B. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-207578 · Cited by 102 · see citing works
Dejaco, C., Duftner, C., Cimmino, M. A., Dasgupta, B., Salvarani, C., Crowson, C. S., Kremers, H. M., Hutchings, A., Matteson, E. L., & Schirmer, M. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.133850 · Cited by 101 · see citing works
Dasgupta, B., Salvarani, C., Schirmer, M., Crowson, C. S., Kremers, H. M., Hutchings, A., & Matteson, E. L. (2008) · PubMed · Cited by 88 · see citing works
Tocilizumab Ameliorates Clinical Symptoms in Polymyalgia Rheumatica: Figure 1.
Hagihara, K., Kawase, I., Tanaka, T., & Kishimoto, T. (2010) · The Journal of Rheumatology · doi:10.3899/jrheum.091185 · Cited by 59 · see citing works
The polymyalgia rheumatica activity score in daily use: Proposal for a definition of remission
Leeb, B. F., Rintelen, B., Sautner, J., Fassl, C., & Bird, H. A. (2007) · Arthritis Care & Research · doi:10.1002/art.22771 · Cited by 58 · see citing works
Performance of the polymyalgia rheumatica activity score for diagnosing disease flares
Binard, A., Bandt, M. D., Berthelot, J., Saraux, A., & Inflammatory Joint Disease Working Group of the French Society for Rheumatology (2008) · Arthritis Care & Research · doi:10.1002/art.23338 · Cited by 55 · see citing works
Self-citationDirect medical costs of polymyalgia rheumatica
Kremers, H. M., Reinalda, M. S., Crowson, C. S., Zinsmeister, A. R., Hunder, G. G., & Gabriel, S. E. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21311 · Cited by 40 · see citing works
Validity of the polymyalgia rheumatica activity score in primary care practice
Binard, A., Lefebvre, B., Bandt, M. D., Berthelot, J. M., & Saraux, A. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.088526 · Cited by 39 · see citing works
Self-citationCleuziou, C., Binard, A., Bandt, M. D., Berthelot, J., & Saraux, A. (2011) · The Journal of Rheumatology · doi:10.3899/jrheum.110866 · Cited by 38 · see citing works
Self-citationTocilizumab is effective against polymyalgia rheumatica: experience in 13 intractable cases
Izumi, K., Kuda, H., Ushikubo, M., Kuwana, M., Takeuchi, T., & Oshima, H. (2015) · RMD Open · doi:10.1136/rmdopen-2015-000162 · Cited by 31 · see citing works
Toussirot, É., MARTIN, A., Soubrier, M., Redeker, S., & Régent, A. (2016) · The Journal of Rheumatology · doi:10.3899/jrheum.150599 · Cited by 28 · see citing works
Current diagnosis and treatment of polymyalgia rheumatica
Bandt, M. D. (2014) · Joint Bone Spine · doi:10.1016/j.jbspin.2013.12.010 · Cited by 13 · see citing works
Naranjo, A., López, R., Garcia-Magallón, B., Cáceres, L., Francisco, F., Jiménez-Palop, M., & Ojeda-Bruno, S. (2014) · Rheumatology International · doi:10.1007/s00296-014-3014-2 · Cited by 7 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Translating IL-6 biology into effective treatments
Choy, E., Benedetti, F. D., Takeuchi, T., Hashizume, M., John, M. R., & Kishimoto, T. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0419-z · Cited by 670 · see citing works
Interleukin (IL-6) ImmunotherapyPreprint
Tanaka, T., Narazaki, M., & Kishimoto, T. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028456 · Cited by 407 · see citing works
González-Gay, M. Á., Matteson, E. L., & Castañeda, S. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31825-1 · Cited by 264 · see citing works
Giant cell arteritis and polymyalgia rheumatica: current challenges and opportunities
Dejaco, C., Brouwer, E., Mason, J. C., Buttgereit, F., Matteson, E. L., & Dasgupta, B. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2017.142 · Cited by 225 · see citing works
Haanen, J., Ernstoff, M. S., Wang, Y., Menzies, A. M., Puzanov, I., Grivas, P., Larkin, J., Peters, S., Thompson, J. A., & Obeid, M. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.03.285 · Cited by 222 · see citing works
The Two-Faced Cytokine IL-6 in Host Defense and Diseases
Narazaki, M., & Kishimoto, T. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113528 · Cited by 207 · see citing works
Autoimmune diseases induced by biological agents. A review of 12,731 cases (BIOGEAS Registry)
Pérez-De-Lis, M., Retamozo, S., Flores-Chávez, A., Kostov, B., Pérez-Álvarez, R., Brito‐Zerón, P., & Ramos‐Casals, M. (2017) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2017.1372421 · Cited by 149 · see citing works
Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper
Spiera, R., Unizony, S. H., Warrington, K. J., Sloane, J., Giannelou, A., Nivens, M. C., Akinlade, B. K., Wong, W., Bhore, R., Lin, Y., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2303452 · Cited by 136 · see citing works
Self-citationDevauchelle‐Pensec, V., Alegria, G. C., Dernis, E., Richez, C., Truchetet, M., Wendling, D., Toussirot, É., Perdriger, A., Gottenberg, J., Felten, R., et al. (2022) · JAMA · doi:10.1001/jama.2022.15459 · Cited by 135 · see citing works
Self-citationLally, L., Forbess, L. J., Hatzis, C., & Spiera, R. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39740 · Cited by 124 · see citing works
Bonelli, M. M., Radner, H., Kerschbaumer, A., Mrak, D., Durechova, M., Stieger, J., Husic, R., Mandl, P., Smolen, J. S., Dejaco, C., et al. (2022) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2021-221126 · Cited by 116 · see citing works
Espígol‐Frigolé, G., Dejaco, C., Mackie, S. L., Salvarani, C., Matteson, E. L., & Cid, M. C. (2023) · The Lancet · doi:10.1016/s0140-6736(23)01310-7 · Cited by 102 · see citing works
Autoimmune manifestations associated with myelodysplastic syndromes
Grignano, É., Jachiet, V., Fenaux, P., Adès, L., Fain, O., & MEKINIAN, A. (2018) · Annals of Hematology · doi:10.1007/s00277-018-3472-9 · Cited by 101 · see citing works
Yang, L., Guo, J., Yu, N., Liu, Y., Song, H., Niu, J., & Gu, Y. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118487 · Cited by 94 · see citing works
Monitoring and long-term management of giant cell arteritis and polymyalgia rheumatica
Camellino, D., Matteson, E. L., Buttgereit, F., & Dejaco, C. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0458-5 · Cited by 84 · see citing works
Diagnostic value of [18F]FDG-PET/CT in polymyalgia rheumatica: a systematic review and meta-analysis
van der Geest, K. S. M., Treglia, G., Glaudemans, A. W. J. M., Brouwer, E., Jamar, F., Slart, R. H. J. A., & Gheysens, O. S. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-05162-6 · Cited by 83 · see citing works
Pathogenesis, Diagnosis and Management of Polymyalgia Rheumatica
Camellino, D., Giusti, A., Girasole, G., Bianchi, G., & Dejaco, C. (2019) · Drugs & Aging · doi:10.1007/s40266-019-00705-5 · Cited by 76 · see citing works
Albrecht, K., Huscher, D., Buttgereit, F., Aringer, M., Hoese, G., Ochs, W., Thiele, K., & Zink, A. (2017) · Rheumatology International · doi:10.1007/s00296-017-3874-3 · Cited by 71 · see citing works
Unizony, S. H., McCulley, T. J., Spiera, R., Pei, J., Sidiropoulos, P. N. M., Best, J. H., Birchwood, C., Pavlov, A., & Stone, J. H. (2021) · Arthritis Research & Therapy · doi:10.1186/s13075-020-02377-8 · Cited by 64 · see citing works
Gholamrezanezhad, A., Basques, K., Batouli, A., Matcuk, G. R., Alavi, A. A., & Jadvar, H. (2018) · American Journal of Roentgenology · doi:10.2214/ajr.17.18523 · Cited by 63 · see citing works
Matteson, E. L., & Dejaco, C. (2017) · Annals of Internal Medicine · doi:10.7326/aitc201705020 · Cited by 60 · see citing works
Marsman, D. E., den Broeder, N., van den Hoogen, F. H. J., den Broeder, A. A., & van der Maas, A. (2021) · The Lancet Rheumatology · doi:10.1016/s2665-9913(21)00245-9 · Cited by 57 · see citing works
The pathophysiology of polymyalgia rheumatica, small pieces of a big puzzle
Alegria, G. C., Boukhlal, S., Cornec, D., & Devauchelle‐Pensec, V. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102670 · Cited by 53 · see citing works
Self-citationKeller, K. K., Mukhtyar, C. B., Nielsen, A., Hemmig, A. K., Mackie, S. L., Sattui, S. E., Hauge, E., Dua, A. B., Helliwell, T., Neill, L. M., et al. (2023) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2023-225134 · Cited by 51 · see citing works
Self-citationKastrati, K., Aletaha, D., Burmester, G. R., Chwala, E., Dejaco, C., Dougados, M., McInnes, I. B., Ravelli, A., Sattar, N. A., Stamm, T., et al. (2022) · RMD Open · doi:10.1136/rmdopen-2022-002359 · Cited by 49 · see citing works
Wendling, D., Tabaa, O. A., Chevet, B., Fakih, O., Ghossan, R., Hecquet, S., Dernis, E., Maheu, E., Saraux, A., Besson, F. L., et al. (2024) · Joint Bone Spine · doi:10.1016/j.jbspin.2024.105730 · Cited by 46 · see citing works
Self-citationSakai, R., Kondo, T., Kurasawa, T., Nishi, E., Okuyama, A., Chino, K., Shibata, A., Okada, Y., Takei, H., Nagasawa, H., et al. (2017) · Clinical Rheumatology · doi:10.1007/s10067-017-3752-0 · Cited by 46 · see citing works
Huwart, A., Garrigues, F., Jousse‐Joulin, S., Marhadour, T., Guellec, D., Cornec, D., Gouillou, M., Saraux, A., & Devauchelle‐Pensec, V. (2018) · Arthritis Research & Therapy · doi:10.1186/s13075-017-1499-2 · Cited by 46 · see citing works
Self-citationSamson, M., Devilliers, H., Ly, K. H., Maurier, F., Bienvenu, B., Terrier, B., Charles, P., Guillevin, L., Besancenot, J.-F., Liozon, É., et al. (2018) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2018.06.008 · Cited by 44 · see citing works
Spiera, R., Unizony, S. H., Bao, M., Luder, Y., Han, J., Pavlov, A., & Stone, J. H. (2021) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2021.03.006 · Cited by 44 · see citing works
Tocilizumab monotherapy for polymyalgia rheumatica: A prospective, single‐center, open‐label study
Chino, K., Kondo, T., Sakai, R., Saito, S., Okada, Y., Shibata, A., Kurasawa, T., Okuyama, A., Takei, H., & Amano, K. (2019) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.13723 · Cited by 42 · see citing works
Saraux, A., Hénaff, C. L., Dernis, E., Alegria, G. C., Tison, A., Quéré, B., Petit, H., Felten, R., Jousse‐Joulin, S., Guellec, D., et al. (2023) · The Lancet Rheumatology · doi:10.1016/s2665-9913(23)00246-1 · Cited by 40 · see citing works
Self-citationTocilizumab in isolated polymyalgia rheumatica: A systematic literature review
Akiyama, M., Kaneko, Y., & Takeuchi, T. (2020) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2019.12.005 · Cited by 40 · see citing works
van der Geest, K. S. M., Sandovici, M., Nienhuis, P. H., Slart, R. H. J. A., Heeringa, P., Brouwer, E., & Jiemy, W. F. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.902155 · Cited by 39 · see citing works
Assessing polymyalgia rheumatica activity when C-reactive protein is unavailable or uninterpretable
Devauchelle‐Pensec, V., Saraux, L., Berthelot, J. M., Bandt, M. D., Cornec, D., Guellec, D., Marhadour, T., Jousse‐Joulin, S., Gouillou, M., & Saraux, A. (2017) · Rheumatology · doi:10.1093/rheumatology/kex477 · Cited by 38 · see citing works
Self-citationAlegria, G. C., Devauchelle‐Pensec, V., Renaudineau, Y., Saraux, A., Pers, J., & Cornec, D. (2017) · Rheumatology · doi:10.1093/rheumatology/kex169 · Cited by 36 · see citing works
Self-citationTaylor, P. C., Feist, E., Pope, J. E., Nash, P. T., Sibilia, J., Caporali, R., & Balsa, A. (2024) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x241283340 · Cited by 33 · see citing works
Saraux, A., Alegria, G. C., Dernis, E., Roux, C. H., Richez, C., Tison, A., Quéré, B., Jousse‐Joulin, S., Guellec, D., Marhadour, T., et al. (2025) · The Lancet Rheumatology · doi:10.1016/s2665-9913(24)00270-4 · Cited by 33 · see citing works
Self-citationEfficacy and safety of tofacitinib in patients with polymyalgia rheumatica: a phase 2 study
Zhang, L., Li, J., Yin, H., Chen, D., Li, Y., Gu, L., Fu, Y., Chen, J., Chen, Z., Yang, S., et al. (2023) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2022-223562 · Cited by 33 · see citing works
Polymyalgia rheumatica: An updated review
Mahmood, S. B., Nelson, E., Padniewski, J. J., & Nasr, R. (2020) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.87a.20008 · Cited by 31 · see citing works
Laporte, J.-P., Garrigues, F., Huwart, A., Jousse‐Joulin, S., Marhadour, T., Guellec, D., Cornec, D., Devauchelle‐Pensec, V., & Saraux, A. (2019) · The Journal of Rheumatology · doi:10.3899/jrheum.180958 · Cited by 30 · see citing works
Self-citationNew insights into the role of imaging in polymyalgia rheumatica
Camellino, D., Duftner, C., & Dejaco, C. (2020) · Rheumatology · doi:10.1093/rheumatology/keaa646 · Cited by 28 · see citing works
Treatment of polymyalgia rheumatica
Castañeda, S., García-Castañeda, N., Prieto-Pena, D., Martínez-Quintanilla, D., Vicente, E. F., Blanco, R., & González-Gay, M. Á. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.03.027 · Cited by 27 · see citing works
Polymyalgia rheumatica: an autoinflammatory disorder?
Floris, A., Piga, M., Cauli, A., Salvarani, C., & Mathieu, A. (2018) · RMD Open · doi:10.1136/rmdopen-2018-000694 · Cited by 25 · see citing works
Polymyalgia Rheumatica: a Common Disease in Seniors
Gazitt, T., Zisman, D., & Gardner, G. C. (2020) · Current Rheumatology Reports · doi:10.1007/s11926-020-00919-2 · Cited by 25 · see citing works
Marsman, D. E., Bolhuis, T. E., den Broeder, N., den Broeder, A. A., & van der Maas, A. (2022) · Trials · doi:10.1186/s13063-022-06263-3 · Cited by 24 · see citing works
Elderly-onset rheumatoid arthritis vs. polymyalgia rheumatica: Differences in pathogenesis
Wu, J., Yang, F., Ma, X., Lin, J., & Chen, W. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2022.1083879 · Cited by 24 · see citing works
Current and emerging therapies in large-vessel vasculitis
Kermani, T. A., & Dasgupta, B. (2017) · Rheumatology · doi:10.1093/rheumatology/kex385 · Cited by 23 · see citing works
Izumi, K., Murata, O., Higashida‐Konishi, M., Kaneko, Y., Oshima, H., & Takeuchi, T. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10132948 · Cited by 23 · see citing works
Genetically proxied IL-6 receptor inhibition and risk of polymyalgia rheumatica
Zhao, S. S., & Gill, D. (2022) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2022-222578 · Cited by 23 · see citing works
Assaraf, M., Chevet, B., Wendling, D., Philippe, P., Cailliau, É., Roux, C. H., Dieudé, P., Ottaviani, S., Avouac, J., Delacour, M., et al. (2023) · Rheumatology · doi:10.1093/rheumatology/kead426 · Cited by 22 · see citing works
Self-citationHas the time come for biotherapies in giant cell arteritis and polymyalgia rheumatica?
Devauchelle‐Pensec, V. (2016) · Joint Bone Spine · doi:10.1016/j.jbspin.2016.07.003 · Cited by 20 · see citing works
Self-citationPolymyalgia rheumatica: An update (Review)
Florescu, M. M., BOBIRCA, F. T., Florescu, A., Pădureanu, V., Bobirca, A. V., Ciurea, P. L., Criveanu, C., Florescu, L. M., & Mușetescu, A. E. (2023) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2023.12242 · Cited by 19 · see citing works
Era of steroid sparing in the management of immune-mediated inflammatory diseases
Kondo, T., & Amano, K. (2018) · Immunological Medicine · doi:10.1080/09114300.2018.1451593 · Cited by 19 · see citing works
Understanding the immunopathophysiology of polymyalgia rheumatica: implications for treatment
Choy, E., Unizony, S. H., Wells, A. F., Dasgupta, B., Buttgereit, F., & Tanaka, Y. (2025) · Annals of the Rheumatic Diseases · doi:10.1016/j.ard.2025.09.005 · Cited by 18 · see citing works
Craig, G. L., Knapp, K. D., Salim, B. A., Mohan, S., & Michalska, M. (2021) · Rheumatology and Therapy · doi:10.1007/s40744-021-00290-3 · Cited by 17 · see citing works
Predicting the risk of relapse in polymyalgia rheumatica: novel insights
Prieto-Pena, D., Castañeda, S., Atienza‐Mateo, B., Blanco, R., & González-Gay, M. Á. (2021) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2021.1890032 · Cited by 16 · see citing works
The Effect of Transcutaneous Vagus Nerve Stimulation in Patients with Polymyalgia Rheumatica
Venborg, J., Wegeberg, A., Kristensen, S., Brock, B., Brock, C., & Pfeiffer‐Jensen, M. (2021) · Pharmaceuticals · doi:10.3390/ph14111166 · Cited by 16 · see citing works
Camellino, D., Soldano, S., Cutolo, M., & Cimmino, M. A. (2018) · Rheumatology International · doi:10.1007/s00296-018-4086-1 · Cited by 16 · see citing works
Hattori, K., Hirano, Y., & Kojima, T. (2020) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.13978 · Cited by 16 · see citing works
Kawka, L., Chevet, B., Arnaud, L., Becker, G., Alegria, G. C., & Felten, R. (2024) · Autoimmunity Reviews · doi:10.1016/j.autrev.2024.103590 · Cited by 15 · see citing works
Recent advances in the diagnosis and treatment of polymyalgia rheumatica
Muratore, F., Pazzola, G., Pipitone, N., & Salvarani, C. (2016) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2016.1178572 · Cited by 15 · see citing works
Efficacy of methotrexate in polymyalgia rheumatica in routine rheumatology clinical care
Ruediger, C. D., Nguyen, L., Black, R. J., Proudman, S., & Hill, C. L. (2020) · Internal Medicine Journal · doi:10.1111/imj.14779 · Cited by 15 · see citing works
Musculotendinous Inflammation: The Defining Pathology of Polymyalgia Rheumatica?
Owen, C., Liew, D. F. L., & Buchanan, R. R. C. (2019) · The Journal of Rheumatology · doi:10.3899/jrheum.190367 · Cited by 15 · see citing works
Buttgereit, F., & Tam, L. (2026) · The Lancet Rheumatology · doi:10.1016/s2665-9913(26)00072-x · Cited by 14 · see citing works
Ughi, N., Sebastiani, G. D., Gerli, R., Salvarani, C., Parisi, S., Ariani, A., Prevete, I., MANARA, M., Rumi, F., Scirè, C. A., et al. (2020) · Reumatismo · doi:10.4081/reumatismo.2020.1268 · Cited by 14 · see citing works
Toussirot, É., Régent, A., Devauchelle‐Pensec, V., Saraux, A., & Puéchal, X. (2016) · RMD Open · doi:10.1136/rmdopen-2016-000305 · Cited by 14 · see citing works
Self-citationTherapeutic response to prednisone in relation to age in polymyalgia rheumatica: a comparison study
Charpentier, A., Verhoeven, F., Sondag, M., Guillot, X., Prati, C., & Wendling, D. (2018) · Clinical Rheumatology · doi:10.1007/s10067-018-3988-3 · Cited by 13 · see citing works
Camellino, D., Dejaco, C., Buttgereit, F., & Matteson, E. L. (2019) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2019.07.005 · Cited by 13 · see citing works
Ponfilly, M. P. D., Séror, R., Nocturne, G., & Besson, F. L. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1070445 · Cited by 12 · see citing works
Abatacept as Adjunctive Therapy in Refractory Polymyalgia Rheumatica
Toussirot, É., Michaud, M., Wendling, D., & Devauchelle‐Pensec, V. (2021) · The Journal of Rheumatology · doi:10.3899/jrheum.210455 · Cited by 12 · see citing works
Self-citationMukhtyar, C. B., Nikiphorou, E., Bartoletti, A., Dey, M., Ducker, G., Misra, D. P., Monti, S., Studenic, P., Berti, A., Blockmans, D., et al. (2026) · Annals of the Rheumatic Diseases · doi:10.1016/j.ard.2026.06.009 · Cited by 11 · see citing works
Satybaldyev, A. M., Demidova, N. V., Savushkina, N. M., & Gordeev, A. V. (2018) · Rheumatology Science and Practice · doi:10.14412/1995-4484-2018-215-227 · Cited by 11 · see citing works
Alegria, G. C., Cornec, D., Renaudineau, Y., Saraux, A., & Devauchelle‐Pensec, V. (2021) · Rheumatology and Therapy · doi:10.1007/s40744-021-00299-8 · Cited by 11 · see citing works
Self-citationBolhuis, T. E., Bösch, P., Falzon, L., Owen, C., Yates, M. M., Mackie, S. L., van der Maas, A., & Dejaco, C. (2024) · Rheumatology · doi:10.1093/rheumatology/keae428 · Cited by 10 · see citing works
Hayashi, K., Ohashi, K., Watanabe, H., Sada, K., Shidahara, K., Asano, Y., Asano, S. H., Yamamura, Y., Miyawaki, Y., Morishita, M., et al. (2019) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x19864822 · Cited by 10 · see citing works
Tocilizumab controls bone turnover in early polymyalgia rheumatica
Alegria, G. C., Garrigues, F., Bettacchioli, É., Lœuille, D., Saraux, A., Cornec, D., Devauchelle‐Pensec, V., & Renaudineau, Y. (2020) · Joint Bone Spine · doi:10.1016/j.jbspin.2020.105117 · Cited by 10 · see citing works
Self-citationPseudo-polyarthrite rhizomélique et artérite à cellules géantes en 2019
Alegria, G. C., Guellec, D., Devauchelle‐Pensec, V., & Saraux, A. (2019) · Revue du Rhumatisme Monographies · doi:10.1016/j.monrhu.2019.02.006 · Cited by 10 · see citing works
Self-citationManaging of giant cell arteritis and polymyalgia rheumatica
González-Gay, M. Á., & Castañeda, S. (2016) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2016.1244480 · Cited by 9 · see citing works
Infection, Immunodeficiency, and Inflammatory Diseases in Autoimmune Neurology
Clardy, S. L., & Piquet, A. L. (2018) · Seminars in Neurology · doi:10.1055/s-0038-1660820 · Cited by 9 · see citing works
Efficacy of JAK Inhibitors versus DMARDs in the Treatment of Polymyalgia Rheumatica in China
Gu, J., Yang, M., Zhang, B., & Wang, H. (2023) · International Journal of General Medicine · doi:10.2147/ijgm.s414267 · Cited by 8 · see citing works
Update on treatment of polymyalgia rheumatica
Camellino, D., & Dejaco, C. (2018) · Reumatismo · doi:10.4081/reumatismo.2018.1062 · Cited by 8 · see citing works
[18F]FDG PET/CT for therapeutic assessment of Abatacept in early-onset polymyalgia rheumatica
Allard, B., Devauchelle‐Pensec, V., Saraux, A., Nowak, E., Tison, A., Boukhlal, S., Guellec, D., Jousse‐Joulin, S., Cornec, D., Marhadour, T., et al. (2023) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-023-06557-x · Cited by 7 · see citing works
Self-citationGarcı́a-Porrúa, C., Heras-Recuero, E., Blázquez-Sánchez, T., Torres-Roselló, A., Castañeda, S., & González-Gay, M. Á. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13216492 · Cited by 7 · see citing works
Efficacy and Safety of Tocilizumab in Polymyalgia Rheumatica: A Systematic Review and Meta‐Analysis
Sharma, M., Das, S. K., Mohindra, R., & Dutta, D. (2025) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.70106 · Cited by 7 · see citing works
The frequency of occult solid malignancy in patients with polymyalgia rheumatica-like symptoms
Ramon, A., Guillibert-Karras, C., Milas-Julien, L., Garrot, J.-F., Maillefert, J.-F., & Ornetti, P. (2021) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x20984275 · Cited by 7 · see citing works
Measurement Properties of the Polymyalgia Rheumatica Activity Score: A Systematic Literature Review
Bolhuis, T. E., Nizet, L. E. A., Owen, C., den Broeder, A. A., van den Ende, C. H. M., & van der Maas, A. (2022) · The Journal of Rheumatology · doi:10.3899/jrheum.211292 · Cited by 7 · see citing works
Okazaki, S., Watanabe, R., Kondo, H., Kudo, M., Harigae, H., & Fujii, H. (2020) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.251.125 · Cited by 6 · see citing works
Desvages, A., Hives, F., Deprez, X., Piérache, A., Behal, H., Flipo, R., & Paccou, J. (2021) · Journal of Clinical Medicine · doi:10.2139/ssrn.3882520 · Cited by 6 · see citing works
Concordance and agreement between different activity scores in polymyalgia rheumatica
D'Agostino, J., Souki, A., Lohse, A., Alegria, G. C., Dernis, E., Richez, C., Truchetet, M., Wendling, D., Toussirot, É., Perdriger, A., et al. (2024) · RMD Open · doi:10.1136/rmdopen-2023-003741 · Cited by 6 · see citing works
Self-citationDrug therapies for polymyalgia rheumatica: a pharmacotherapeutic update
González-Gay, M. Á., Pina, T., Prieto-Pena, D., Calderón-Goercke, M., Blanco, R., & Castañeda, S. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1501360 · Cited by 6 · see citing works
Shiraishi, K., Masei, S. U. D. A., ROKUTANDA, R., KISHIMOTO, M., & OKADA, M. (2018) · Archives of Rheumatology · doi:10.5606/archrheumatol.2018.6418 · Cited by 6 · see citing works
Lally, L., & Spiera, R. (2018) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2019.04.006 · Cited by 6 · see citing works
Tocilizumab in recent polymyalgia rheumatica: how can we manage the interleukin-6 blockage?
Devauchelle‐Pensec, V., & Saraux, A. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209607 · Cited by 6 · see citing works
Self-citationIs Tocilizumab as efficient as steroids early in polymyalgia rheumatica?
Alegria, G. C., Saraux, A., & Devauchelle‐Pensec, V. (2020) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2020.04.013 · Cited by 6 · see citing works
Self-citationMadec, A. L., Querellou, S., Binard, A., Saraux, A., Quéré, B., Marhadour, T., Jousse‐Joulin, S., Tison, A., Cornec, D., Guellec, D., et al. (2025) · Joint Bone Spine · doi:10.1016/j.jbspin.2025.105950 · Cited by 5 · see citing works
Self-citationMethoden zur Erfassung der Krankheitsaktivität der Polymyalgia rheumatica
Reisch, M., & Dejaco, C. (2023) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-023-01358-x · Cited by 5 · see citing works
Steroid-sparing agents in polymyalgia rheumatica: how will they fit into the treatment paradigm?
Ricordi, C., Pipitone, N., Marvisi, C., Muratore, F., & Salvarani, C. (2023) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2023.2240519 · Cited by 5 · see citing works
Prevention of bleomycin-induced pulmonary fibrosis by vaccination with the Tocilizumab mimotope
Guo, J., Yang, L., Song, H., & Bai, L. (2024) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2024.2319965 · Cited by 5 · see citing works
Nasonov, E. L., Satybaldyev, A. M., Otteva, E. N., Beketova, T. V., & Baranov, A. A. (2024) · Rheumatology Science and Practice · doi:10.47360/1995-4484-2024-348-364 · Cited by 5 · see citing works
- Authors
- Devauchelle-Pensec, V., Berthelot, J. M., Cornec, D., Renaudineau, Y., Marhadour, T., Jousse-Joulin, S., Querellou, S., Garrigues, F., De Bandt, M., Gouillou, M., & Saraux, A.
- Affiliations
- Centre Hospitalier Universitaire de Nantes (FR)
- Université de Bretagne Occidentale (FR)
- Venue
- Annals of the Rheumatic Diseases
- Publisher
- Elsevier BV
- Published
- 2016-08
- Volume
- 75
- Issue
- 8
- Pages
- 1506-1510
- ISSN
- 0003-4967 (ISSN-L)
- PMC
- PMC4975852
- OpenAlex
- W2290444582
- Cited by
- 171
- References
- 22
- Citations by year
- 2026: 15 · 2025: 10 · 2024: 18 · 2023: 19 · 2022: 19 · 2021: 17 · 2020: 19 · 2019: 11 · 2018: 18 · 2017: 16 · 2016: 8
- FWCI
- 15.80
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Annals of the Rheumatic Diseases (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- Chugai Pharmaceutical
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Vasculitis and related conditions
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Health Sciences › Medicine › Rheumatology › Otitis Media and Relapsing Polychondritis
- Keywords
- tocilizumab, polymyalgia rheumatica, steroid-sparing therapy, prednisone, IL-6 inhibition, neutropenia, leukopenia, treatment efficacy and safety
- MeSH terms
- Positron Emission Tomography Computed Tomography, Aged, Drug Administration Schedule, Drug Therapy, Combination, Female, Glucocorticoids, Humans, Infusions, Intravenous, Longitudinal Studies, Male, Middle Aged, Polymyalgia Rheumatica, Prednisone, Prospective Studies, Severity of Illness Index, Treatment Outcome, Antirheumatic Agents, Antibodies, Monoclonal, Humanized
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
